Evidence map›Paper›PMID 31293425›Full record

ArticleFrontiers in pharmacology2019

Is Danggui Safe to be Taken by Breast Cancer Patients?-A Skepticism Finally Answered by Comprehensive Preclinical Evidence.

Grace Gar-Lee Yue, Lok-Sze Wong, Hoi-Wing Leung, Si Gao, Julia Yuen-Shan Tsang, Zhi-Xiu Lin, Bonita Ka-Bo Law, Gary Man-Kit Tse, Clara Bik-San Lau

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. A population-based case-control study on the association ofJournal of traditional and complementary medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Grace Gar-Lee YueInstitute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Lok-Sze WongInstitute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Hoi-Wing LeungInstitute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Si GaoInstitute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Julia Yuen-Shan TsangDepartment of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Zhi-Xiu LinSchool of Chinese Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.
Bonita Ka-Bo LawUnion Hospital, Shatin, Hong Kong.
Gary Man-Kit TseDepartment of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Clara Bik-San LauInstitute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Chinese University of Hong Kong · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angelica sinensisbreast cancerChinese herbal medicinesestrogenic herbsprimary breast cancer cellssafety

Identifiers

PMID31293425
PMCPMC6604035
OpenAlexW2953455675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.